{{Rsnum
|rsid=9348440
|Gene=CDKAL1
|Chromosome=6
|position=20641105
|Orientation=plus
|GMAF=0.1892
|Gene_s=CDKAL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 80.5 | 17.7 | 1.8
| HCB | 35.0 | 51.8 | 13.1
| JPT | 35.7 | 50.9 | 13.4
| YRI | 72.1 | 26.5 | 1.4
| ASW | 84.2 | 14.0 | 1.8
| CHB | 35.0 | 51.8 | 13.1
| CHD | 40.4 | 41.3 | 18.3
| GIH | 68.3 | 29.7 | 2.0
| LWK | 86.4 | 11.8 | 1.8
| MEX | 60.7 | 35.7 | 3.6
| MKK | 75.2 | 24.2 | 0.7
| TSI | 79.4 | 19.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23575436
  |Trait=Glycemic traits
  |Title=New susceptibility loci in MYL2, C12orf51 and OAS1 associated with 1-h plasma glucose as predisposing risk factors for type 2 diabetes in the Korean population.
  |RiskAllele=A
  |Pval=3E-19
  |OR=.25
  |ORtxt=[0.19-0.30] mmol-1 increase
  }}

{{ population diversity
| geno1 = (C;C)
| geno2 = (C;T)
| geno3 = (T;T)
| CEU | 80.0 | 18.3 | 1.7
| HCB | 35.6 | 51.1 | 13.3
| JPT | 42.2 | 44.4 | 13.3
| YRI | 70.0 | 30.0 | 0.0
| ASW | 83.7 | 14.3 | 2.0
| CHD | 41.2 | 40.0 | 18.8
| GIH | 69.3 | 29.5 | 1.1
| LWK | 86.7 | 11.1 | 2.2
| MEX | 62.5 | 33.3 | 4.2
| MKK | 75.0 | 24.3 | 0.7
| TSI | 80.7 | 18.2 | 1.1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}